Product
SGLT-2 inhibitor
1 clinical trial
3 indications
Indication
Chronic Kidney DiseaseIndication
ChronicClinical trial
The Efficacy and Safety of SGLT2 Inhibitors in Improving Heart Failure in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) and Severe Renal InsufficiencyStatus: Terminated, Estimated PCD: 2024-04-16